Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00111020
What this trial is testing

Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 2,567
Testing effectiveness (Phase 2)UnknownNCT05879497
What this trial is testing

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT03875313
What this trial is testing

Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaTNBC - Triple-Negative Breast Cancer+4 more
Calithera Biosciences, Inc 33
Not applicableUnknownNCT04666220
What this trial is testing

VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma

Who this might be right for
Renal Cell CarcinomaAdrenal Carcinoma
Humanitas Clinical and Research Center 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT05148546
What this trial is testing

Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer

Who this might be right for
Renal Cell Carcinoma
The Netherlands Cancer Institute 69
Not applicableStudy completedNCT05070637
What this trial is testing

Circulating Tumor Cell Reducing No-touch Nephrectomy

Who this might be right for
Renal Cell CarcinomaCirculating Tumor Cell
Hospital de Santa Maria, Portugal 44
Testing effectiveness (Phase 2)UnknownNCT04631731
What this trial is testing

Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity

Who this might be right for
Lung Cancer, Nonsmall CellRenal Cell CarcinomaMelanoma+4 more
Western Sydney Local Health District 200
Not applicableWithdrawnNCT02307474
What this trial is testing

A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRenal Cell Carcinoma
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00422786
What this trial is testing

Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Thallion Pharmaceuticals 10
Post-approval studies (Phase 4)Ended earlyNCT02338570
What this trial is testing

Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE)

Who this might be right for
Renal Cell Carcinoma
Mario Negri Institute for Pharmacological Research 31
Testing effectiveness (Phase 2)Ended earlyNCT01673386
What this trial is testing

A Subject Treatment Preference Study of Tivozanib Versus Sunitinib in Subjects With Metastatic RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
AVEO Pharmaceuticals, Inc. 58
Testing effectiveness (Phase 2)Study completedNCT03967522
What this trial is testing

Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases

Who this might be right for
Metastatic Renal Cell Carcinoma
Centre Leon Berard 26
Early research (Phase 1)UnknownNCT05468190
What this trial is testing

A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Chongqing Precision Biotech Co., Ltd 48
Testing effectiveness (Phase 2)Study completedNCT00378703
What this trial is testing

Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 361
Not applicableStudy completedNCT00970970
What this trial is testing

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease

Who this might be right for
Von Hippel-Lindau DiseaseHemangioblastomaRenal Cell Carcinoma+2 more
University Medical Center Groningen 22
Early research (Phase 1)Ended earlyNCT03483883
What this trial is testing

Avelumab/Gemcitabine in Sarcomatoid RCC

Who this might be right for
Metastatic sRCC
Abramson Cancer Center at Penn Medicine 6
Testing effectiveness (Phase 2)Study completedNCT03294083
What this trial is testing

Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
SillaJen, Inc. 95
Testing effectiveness (Phase 2)UnknownNCT06221774
What this trial is testing

Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors

Who this might be right for
Clear Cell Renal CarcinomaUrothelial CarcinomaMetastatic Castration-resistant Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 42
Testing effectiveness (Phase 2)UnknownNCT00890110
What this trial is testing

Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib

Who this might be right for
Renal Cell Cancer
Hadassah Medical Organization 13
Not applicableStudy completedNCT04316520
What this trial is testing

Ketogenic Diet for Patients Receiving Treatment for Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cancer
University Hospital, Angers 20
Next Page